Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenue:
Revenue	$ 196,830	$ 110,399	$ 568,839	$ 250,214
Operating expenses:
Cost of sales	33,557	22,410	76,867	38,598
Research and development	88,569	79,421	251,216	285,105
Selling, general and administrative	121,984	145,648	379,571	359,114
Total operating expenses:	244,110	247,479	707,654	682,817
Net operating loss	(47,280)	(137,080)	(138,815)	(432,603)
Loss on extinguishment of development liability			(1,949)
Interest income	2,889	4,989	9,377	16,385
Interest expense	(12,532)	(7,310)	(28,857)	(22,179)
Other income/(expense), net	70	(603)	(405)	(946)
Net loss before taxes	(56,853)	(140,004)	(160,649)	(439,343)
Income tax expense	592	233	876	709
Net loss	(57,445)	(140,237)	(161,525)	(440,052)
Other comprehensive gain/(loss):
Foreign currency translation	222	(269)	402	(190)
Total other comprehensive income	222	(269)	402	(190)
Comprehensive loss, net of tax	$ (57,223)	$ (140,506)	$ (161,123)	$ (440,242)
Net loss per common share, basic	$ (0.46)	$ (1.17)	$ (1.31)	$ (3.73)
Net loss per common share, diluted	$ (0.46)	$ (1.17)	$ (1.31)	$ (3.73)
Weighted-average number of common shares used in net loss per common share, basic	124,234	120,292	123,698	117,827
Weighted-average number of common shares used in net loss per common share, diluted	124,234	120,292	123,698	117,827
Product Revenue, Net [Member]
Revenue:
Revenue	$ 176,571	$ 99,182	$ 518,782	$ 227,626
Licensing and other revenue [Member]
Revenue:
Revenue	$ 20,259	$ 11,217	$ 50,057	$ 22,588